We conducted a dose-response study in 23 postmenopausal women to compare the physiologic effects of transdermal estradiol and oral conjugated equine estrogens. The doses studied were 25, 50, 100, and 200 micrograms of transdermal estradiol per 24 hours, and 0.625 and 1.25 mg of oral conjugated estrogens. Transdermal estradiol increased circulating concentrations of estradiol and estrone. Oral conjugated estrogens also raised the levels of estrogen, particularly estrone. Both preparations lowered gonadotropin levels, decreased the percentages of vaginal parabasal cells, increased the percentage of superficial cells, and lowered urinary calcium excretion. The effects of 0.625 and 1.25 mg of oral estrogens were similar to those of 50 and 100 micrograms of transdermal estradiol per 24 hours, respectively. Oral estrogens significantly increased circulating levels of renin substrate, sex-hormone-binding globulin, thyroxine-binding globulin, and cortisol-binding globulin; transdermal estradiol had no effect. The higher dose of oral estrogens had favorable effects on concentrations of low-density and high-density lipoproteins, but transdermal estradiol did not. Neither preparation affected any of the four clotting factors studied. These data indicate that transdermal estradiol can elicit many of the desirable actions of estrogen while avoiding the pharmacologic effects of oral estrogens on hepatic proteins.
This article has been cited by other articles:
Corrao, G., Zambon, A., Conti, V., Nicotra, F., La Vecchia, C., Fornari, C., Cesana, G., Contiero, P., Tagliabue, G., Nappi, R. E., Merlino, L.
(2008). Menopause hormone replacement therapy and cancer risk: an Italian record linkage investigation. Ann Oncol
19: 150-155
[Abstract][Full Text]
Arafah, B. M., Nishiyama, F. J., Tlaygeh, H., Hejal, R.
(2007). Measurement of Salivary Cortisol Concentration in the Assessment of Adrenal Function in Critically Ill Subjects: A Surrogate Marker of the Circulating Free Cortisol. J. Clin. Endocrinol. Metab.
92: 2965-2971
[Abstract][Full Text]
Turgeon, J. L., Carr, M. C., Maki, P. M., Mendelsohn, M. E., Wise, P. M.
(2006). Complex Actions of Sex Steroids in Adipose Tissue, the Cardiovascular System, and Brain: Insights from Basic Science and Clinical Studies. Endocr. Rev.
27: 575-605
[Abstract][Full Text]
Eliassen, A. H., Colditz, G. A., Rosner, B., Willett, W. C., Hankinson, S. E.
(2006). Adult weight change and risk of postmenopausal breast cancer.. JAMA
296: 193-201
[Abstract][Full Text]
Bisschop, P. H, Toorians, A. W, Endert, E., Wiersinga, W. M, Gooren, L. J, Fliers, E.
(2006). The effects of sex-steroid administration on the pituitary-thyroid axis in transsexuals.. Eur J Endocrinol
155: 11-16
[Abstract][Full Text]
Bahamondes, L., Espejo-Arce, X., Hidalgo, M. M., Hidalgo-Regina, C., Teatin-Juliato, C., Petta, C. A.
(2006). A cross-sectional study of the forearm bone density of long-term users of levonorgestrel-releasing intrauterine system. Hum Reprod
21: 1316-1319
[Abstract][Full Text]
Kalantaridou, S. N., Calis, K. A., Mazer, N. A., Godoy, H., Nelson, L. M.
(2005). A Pilot Study of an Investigational Testosterone Transdermal Patch System in Young Women with Spontaneous Premature Ovarian Failure. J. Clin. Endocrinol. Metab.
90: 6549-6552
[Abstract][Full Text]
Mah, P. M., Webster, J., Jonsson, P., Feldt-Rasmussen, U., Koltowska-Haggstrom, M., Ross, R. J. M.
(2005). Estrogen Replacement in Women of Fertile Years with Hypopituitarism. J. Clin. Endocrinol. Metab.
90: 5964-5969
[Abstract][Full Text]
T'Sjoen, G. G, Beguin, Y., Feyen, E., Rubens, R., Kaufman, J.-M., Gooren, L.
(2005). Influence of exogenous oestrogen or (anti-) androgen administration on soluble transferrin receptor in human plasma. J Endocrinol
186: 61-67
[Abstract][Full Text]
Harvie, M., Howell, A., Vierkant, R. A., Kumar, N., Cerhan, J. R., Kelemen, L. E., Folsom, A. R., Sellers, T. A.
(2005). Association of Gain and Loss of Weight before and after Menopause with Risk of Postmenopausal Breast Cancer in the Iowa Women's Health Study. Cancer Epidemiol. Biomarkers Prev.
14: 656-661
[Abstract][Full Text]
Giltay, E. J, Gooren, L. J., Toorians, A. W., Katan, M. B, Zock, P. L
(2004). Docosahexaenoic acid concentrations are higher in women than in men because of estrogenic effects. Am. J. Clin. Nutr.
80: 1167-1174
[Abstract][Full Text]
Leung, K.-C., Johannsson, G., Leong, G. M., Ho, K. K. Y.
(2004). Estrogen Regulation of Growth Hormone Action. Endocr. Rev.
25: 693-721
[Abstract][Full Text]
Hamrahian, A. H., Oseni, T. S., Arafah, B. M.
(2004). Measurements of Serum Free Cortisol in Critically Ill Patients. NEJM
350: 1629-1638
[Abstract][Full Text]
Welt, C. K., Pagan, Y. L., Smith, P. C., Rado, K. B., Hall, J. E.
(2003). Control of Follicle-Stimulating Hormone by Estradiol and the Inhibins: Critical Role of Estradiol at the Hypothalamus during the Luteal-Follicular Transition. J. Clin. Endocrinol. Metab.
88: 1766-1771
[Abstract][Full Text]
Evans, M. J., Harris, H. A., Miller, C. P., Karathanasis, S. K., Adelman, S. J.
(2002). Estrogen Receptors {alpha} and {beta} Have Similar Activities in Multiple Endothelial Cell Pathways. Endocrinology
143: 3785-3795
[Abstract][Full Text]
Lemay, A., Dodin, S., Kadri, N., Jacques, H., Forest, J.-C.
(2002). Flaxseed Dietary Supplement Versus Hormone Replacement Therapy in Hypercholesterolemic Menopausal Women. Obstet Gynecol
100: 495-504
[Abstract][Full Text]
Nicholls, J., Lasley, B. L., Nakajima, S. T., Setchell, K. D. R., Schneeman, B. O.
(2002). Effects of Soy Consumption on Gonadotropin Secretion and Acute Pituitary Responses to Gonadotropin-Releasing Hormone in Women. J. Nutr.
132: 708-714
[Abstract][Full Text]
Mikkola, T. S, Clarkson, T. B
(2002). Estrogen replacement therapy, atherosclerosis, and vascular function. Cardiovasc Res
53: 605-619
[Abstract][Full Text]
Fischer, M., Baessler, A., Schunkert, H.
(2002). Renin angiotensin system and gender differences in the cardiovascular system. Cardiovasc Res
53: 672-677
[Abstract][Full Text]
Wolthers, T., Hoffman, D. M., Nugent, A. G., Duncan, M. W, Umpleby, M., Ho, K. K. Y.
(2001). Oral estrogen antagonizes the metabolic actions of growth hormone in growth hormone-deficient women. Am. J. Physiol. Endocrinol. Metab.
281: E1191-E1196
[Abstract][Full Text]
Utiger, R. D.
(2001). Estrogen, Thyroxine Binding in Serum, and Thyroxine Therapy. NEJM
344: 1784-1785
[Full Text]
Vehkavaara, S., Hakala-Ala-Pietila, T., Virkamaki, A., Bergholm, R., Ehnholm, C., Hovatta, O., Taskinen, M.-R., Yki-Jarvinen, H.
(2000). Differential Effects of Oral and Transdermal Estrogen Replacement Therapy on Endothelial Function in Postmenopausal Women. Circulation
102: 2687-2693
[Abstract][Full Text]
Marqusee, E., Braverman, L. E., Lawrence, J. E., Carroll, J. S., Seely, E. W.
(2000). The Effect of Droloxifene and Estrogen on Thyroid Function in Postmenopausal Women. J. Clin. Endocrinol. Metab.
85: 4407-4410
[Abstract][Full Text]
Mosca, L.
(2000). The Role of Hormone Replacement Therapy in the Prevention of Postmenopausal Heart Disease. Arch Intern Med
160: 2263-2272
[Abstract][Full Text]
Giltay, E. J., Gooren, L. J. G., Emeis, J. J., Kooistra, T., Stehouwer, C. D. A.
(2000). Oral, but Not Transdermal, Administration of Estrogens Lowers Tissue-Type Plasminogen Activator Levels in Humans Without Affecting Endothelial Synthesis. Arterioscler. Thromb. Vasc. Bio.
20: 1396-1403
[Abstract][Full Text]
Karjalainen, A., Heikkinen, J., Savolainen, M. J., Backstrom, A.-C., Kesaniemi, Y. A.
(2000). Mechanisms Regulating LDL Metabolism in Subjects on Peroral and Transdermal Estrogen Replacement Therapy. Arterioscler. Thromb. Vasc. Bio.
20: 1101-1106
[Abstract][Full Text]
Duncan, A. M., Underhill, K. E.W., Xu, X., LaValleur, J., Phipps, W. R., Kurzer, M. S.
(1999). Modest Hormonal Effects of Soy Isoflavones in Postmenopausal Women. J. Clin. Endocrinol. Metab.
84: 3479-3484
[Abstract][Full Text]
Garnero, P., Tsouderos, Y., Marton, I., Pelissier, C., Varin, C., Delmas, P. D.
(1999). Effects of Intranasal 17{beta}-Estradiol on Bone Turnover and Serum Insulin-Like Growth Factor I in Postmenopausal Women. J. Clin. Endocrinol. Metab.
84: 2390-2397
[Abstract][Full Text]
Uhler, M. L., Marks, J. W., Voigt, B. J., Judd, H. L.
(1998). Comparison of the Impact of Transdermal Versus Oral Estrogens on Biliary Markers of Gallstone Formation in Postmenopausal Women. J. Clin. Endocrinol. Metab.
83: 410-414
[Abstract][Full Text]
Slayden, S. M., Crabbe, L., Bae, S., Potter, H. D., Azziz, R., Parker, C. R. Jr.
(1998). The Effect of 17{beta}-Estradiol on Adrenocortical Sensitivity, Responsiveness, and Steroidogenesis in Postmenopausal Women. J. Clin. Endocrinol. Metab.
83: 519-524
[Abstract][Full Text]
Gravholt, C. H., Naeraa, R. W., Fisker, S., Christiansen, J. S.
(1997). Body Composition and Physical Fitness Are Major Determinants of the Growth Hormone-Insulin-Like Growth Factor Axis Aberrations in Adult Turner's Syndrome, with Important Modulations by Treatment with 17{beta}-Estradiol. J. Clin. Endocrinol. Metab.
82: 2570-2577
[Abstract][Full Text]
Lundeen, S. G., Carver, J. M., McKean, M.-L., Winneker, R. C.
(1997). Characterization of the Ovariectomized Rat Model for the Evaluation of Estrogen Effects on Plasma Cholesterol Levels. Endocrinology
138: 1552-1558
[Abstract][Full Text]
Colditz, G. A., Hankinson, S. E., Hunter, D. J., Willett, W. C., Manson, J. E., Stampfer, M. J., Hennekens, C., Rosner, B., Speizer, F. E.
(1995). The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women. NEJM
332: 1589-1593
[Abstract][Full Text]
Henderson, B., Ross, R., Pike, M.
(1993). Hormonal chemoprevention of cancer in women. Science
259: 633-638
[Abstract]
Previous
